# Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage

> **NCT01179529** · PHASE2 · COMPLETED · sponsor: **Technical University of Munich**

## Conditions studied

- Atopic Dermatitis
- Atopic Eczema

## Interventions

- **DRUG:** Omalizumab (Xolair®)

## Key facts

- **NCT ID:** NCT01179529
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01179529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01179529, "Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01179529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*